<GlossaryTerm id="CDR0000386204"><TermName>gp209-2M</TermName><TermDefinition><DefinitionText>A peptide (short piece of protein) made from the tumor-specific antigen gp100, and used to make vaccines being studied in the treatment of melanoma.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>gp209-2M</SpanishTermName><SpanishTermDefinition><DefinitionText>Un péptido (segmento corto de proteína) elaborado del antígeno gp100 tumoral específico y que se usa para producir vacunas que se encuentran en estudio para el tratamiento del melanoma.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-08-24</DateFirstPublished></GlossaryTerm>
